Home » MGI CLOSES GUILFORD DEAL, UPDATES OUTLOOK
MGI CLOSES GUILFORD DEAL, UPDATES OUTLOOK
Drug maker MGI Pharma Inc. closed its purchase of Guilford Pharmaceuticals Inc. on Monday and revised its guidance for the year -- widening its revenue outlook and saying certain expenses will be higher than previously projected. MGI paid $179.6 million in cash and stock for Guilford and assumed certain debt of the maker of the Gliadel cancer-treatment wafer.
MSN Money (http://news.moneycentral.msn.com/provider/providerarticle.asp?feed=AP&Date=20051003&ID=5162343)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May